These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 29999603)

  • 1. Sustained lung inflation at birth via short binasal prong in very low birth weight preterm infants: A retrospective study.
    Buyuktiryaki M; Kanmaz HG; Okur N; Bezirganoglu H; Ozer Bekmez B; Simsek GK; Canpolat FE; Oguz SS; Tayman C
    Pediatr Pulmonol; 2018 Oct; 53(10):1407-1413. PubMed ID: 29999603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binasal Prong versus Nasal Mask for Applying CPAP to Preterm Infants: A Randomized Controlled Trial.
    Say B; Kanmaz Kutman HG; Oguz SS; Oncel MY; Arayici S; Canpolat FE; Uras N; Karahan S
    Neonatology; 2016; 109(4):258-64. PubMed ID: 26859512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.
    De Paoli AG; Davis PG; Faber B; Morley CJ
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD002977. PubMed ID: 18254011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained lung inflation at birth for preterm infants: a randomized clinical trial.
    Lista G; Boni L; Scopesi F; Mosca F; Trevisanuto D; Messner H; Vento G; Magaldi R; Del Vecchio A; Agosti M; Gizzi C; Sandri F; Biban P; Bellettato M; Gazzolo D; Boldrini A; Dani C;
    Pediatrics; 2015 Feb; 135(2):e457-64. PubMed ID: 25624390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained lung inflation in the delivery room in preterm infants at high risk of respiratory distress syndrome (SLI STUDY): study protocol for a randomized controlled trial.
    Dani C; Lista G; Pratesi S; Boni L; Agosti M; Biban P; Del Vecchio A; Gazzolo D; Gizzi C; Magaldi R; Messner H; Mosca F; Sandri F; Scopesi F; Trevisanuto D; Vento G
    Trials; 2013 Mar; 14():67. PubMed ID: 23497495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.
    De Paoli AG; Davis PG; Faber B; Morley CJ
    Cochrane Database Syst Rev; 2002; (4):CD002977. PubMed ID: 12519580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
    Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
    PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of invasive mechanic ventilation/surfactant therapy and non-invasive nasal-continuous positive airway pressure in preterm newborns.
    Celik M; Bulbul A; Uslu S; Dursun M; Guran O; Kıray Bas E; Arslan S; Zubarioglu U
    J Matern Fetal Neonatal Med; 2018 Dec; 31(24):3225-3231. PubMed ID: 28856971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 12. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early or later prophylactic INSURE in preterm infants of less than 30 weeks' gestation.
    Okulu E; Arsan S; Mungan Akın İ; Alan S; Kılıç A; Atasay B
    Turk J Pediatr; 2015; 57(1):1-8. PubMed ID: 26613214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sustained Lung Inflation, a lung recruitment maneuver in primary acute respiratory distress syndrome, in respiratory and cerebral outcomes in preterm infants.
    Grasso C; Sciacca P; Giacchi V; Carpinato C; Mattia C; Palano GM; Betta P
    Early Hum Dev; 2015 Jan; 91(1):71-5. PubMed ID: 25549915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial.
    Kanmaz HG; Erdeve O; Canpolat FE; Mutlu B; Dilmen U
    Pediatrics; 2013 Feb; 131(2):e502-9. PubMed ID: 23359581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.